Cell Wall N-glycan of Candida Albicans Ameliorates Early Hyper- and Late Hypo-immunoreactivity in Sepsis
Overview
Authors
Affiliations
Severe infection often causes a septic cytokine storm followed by immune exhaustion/paralysis. Not surprisingly, many pathogens are equipped with various anti-inflammatory mechanisms. Such mechanisms might be leveraged clinically to control septic cytokine storms. Here we show that N-glycan from pathogenic C. albicans ameliorates mouse sepsis through immunosuppressive cytokine IL-10. In a sepsis model using lipopolysaccharide (LPS), injection of the N-glycan upregulated serum IL-10, and suppressed pro-inflammatory IL-1β, TNF-α and IFN-γ. The N-glycan also improved the survival of mice challenged by LPS. Analyses of structurally defined N-glycans from several yeast strains revealed that the mannose core is key to the upregulation of IL-10. Knocking out the C-type lectin Dectin-2 abrogated the N-glycan-mediated IL-10 augmentation. Furthermore, C. albicans N-glycan ameliorated immune exhaustion/immune paralysis after acute inflammation. Our results suggest a strategy where the immunosuppressive mechanism of one pathogen can be applied to attenuate a severe inflammation/cytokine storm caused by another pathogen.
Impact of different pathogen classes on the serum -glycome in septic shock.
Torpy H, Chau T, Chatterjee S, Chernykh A, Torpy D, Meyer E BBA Adv. 2025; 7:100138.
PMID: 39877544 PMC: 11773048. DOI: 10.1016/j.bbadva.2025.100138.
An immune-adrenergic pathway induces lethal levels of platelet-activating factor in mice.
Tanaka S, Kawakita M, Yasui H, Sudo K, Itoh F, Sasaki M Commun Biol. 2024; 7(1):782.
PMID: 38951147 PMC: 11217416. DOI: 10.1038/s42003-024-06498-7.
Li S, Liu Y, Weng L, Zhao Y, Zhang Y, Zhang Z Virulence. 2023; 14(1):2190645.
PMID: 36914568 PMC: 10072111. DOI: 10.1080/21505594.2023.2190645.
Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids.
Correia-Neves M, Nigou J, Mousavian Z, Sundling C, Kallenius G Front Immunol. 2022; 13:1035122.
PMID: 36544778 PMC: 9761185. DOI: 10.3389/fimmu.2022.1035122.
Defective antifungal immunity in patients with COVID-19.
Morton C, Griffiths J, Loeffler J, Orr S, White P Front Immunol. 2022; 13:1080822.
PMID: 36531987 PMC: 9750792. DOI: 10.3389/fimmu.2022.1080822.